Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMG 181 in Moderate to Severe Ulcerative Colitis
2011-005251-13Phase 2Completed
- Sponsor
- Amgen
- Start
- May 2012
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of abrilumab in autoimmune colitis, sponsored by Amgen. Started May 2012; status: completed.
02
Drugs
abrilumab
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on 2011-005251-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005251-13.